Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005117:Cardiac Complexes, Premature; D003331:Coronary Vessels / Q000601:surgery; D004285:Dogs; D004566:Electrodes; D005452:Fluoresceins / Q000494:pharmacology / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects*; D008026:Ligation; D008628:Mercury / Q000494:pharmacology / Q000627:therapeutic use*; D009119:Muscle Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy*; D012032:Refractory Period, Electrophysiological; D013610:Tachycardia; D013997:Time Factors; D014672:Vectorcardiography; D014693:Ventricular Fibrillation
D005452:Fluoresceins; D008628:Mercury